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Abstract
Ideal volume status of patients with end-stage renal disease is one of the main goals of
adequate dialysis. Volume overload has been associated with heart failure, left ventric‐
ular hypertrophy, and mortality, both in hemodialysis (HD) and peritoneal dialysis (PD)
populations. The assessment of normal volume status is traditionally based on clinical
parameters such as blood pressure, edema, lung auscultation, and chest X-ray. Howev‐
er, these parameters cannot be trustworthy to direct treatment decisions. Gold standard
methods of assessing volume status are mainly isotope dilution analysis techniques.
However, these methods are invasive and impractical in clinical routine. A number of
handy  bedside  methods  have  been  developed  focusing  on  objective  fluid  status
assessment,  both  in  HD  and  PD  patients.  Bioimpedance  techniques  can  estimate
extracellular volume, intracellular volume, and total body water, whereas inferior vena
cava  diameter  measurements,  biochemical  markers,  and  lung  ultrasound  provide
information about the intravascular filling state and blood volume. Various studies have
used  the  values  of  the  above-mentioned  techniques  as  tools  for  determining  the
overhydration of dialysis patients as well as predictors of mortality. Yet, randomized
intervention studies based on these methods with hard end points (like echocardio‐
graphic parameters modification) have not been published so far in PD patients.
Keywords: bioimpedance, hemodialysis, lung ultrasound, biomarkers, overhydration,
mortality
1. Introduction
Ideal volume status of patients with end-stage renal disease is one of the main objectives of
adequate dialysis. Volume overload has been associated with heart failure, left ventricular
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hypertrophy, and mortality both in hemodialysis (HD) and peritoneal dialysis (PD) popula‐
tions [1–5]. One routine clinical way to define volume status is to determine the ideal dry weight
of the patients. While dry weight in HD patients has been attempted vigorously to be termed
during the last decades [6], such efforts have never been done systematically in PD popula‐
tions, mainly due to the different nature of the dialysis procedure. Krediet [7] suggested to define
optimal volume status as the weight associated with a normal extracellular water/volume (ECV).
Technique What is estimated Advantages Limitations
Dilution tracers ECV, TBW Gold standard method Invasive, not for everyday clinical
practice
IVC Intravascular filling–BV Correlation with cardiac
Function, noninvasive
Experienced cardiologist
Bioimpedance ECV, ICV, TBW Easy, noninvasive, fluid
volumes in liters
No standardization
Influenced by hypoalbuminemia
and muscle wasting
Biomarkers Intravascular filling–BV Noninvasive Wide variability
Influenced by cardiac
dysfunction
Lung ultrasound Intravascular filling–BV Noninvasive, easy No estimation of TBW, ECV
Little experience in PD
IVC, inferior vena cava diameter; ECV, extracellular volume; ICV, intracellular volume; TBW, total body water; BV,
blood volume.
Table 1. Techniques for assessment of volume status in PD populations.
The assessment of euvolemia—normal volume status—is traditionally based on clinical
parameters and examinations such as blood pressure, edema, lung auscultation, and chest X-
ray. However, these parameters cannot be reliable to guide treatment decisions. Agarwal et
al. [8], in a cross-sectional trial in HD population, showed that pedal edema did not reflect
volume status. No study so far has showed a direct relation between clinically assessed fluid
overload and outcome in PD patients. Despite the lack of such trials, ISPD guidelines suggest
that “hydration status should be assessed clinically on a regular basis during every follow-up
visit and more often if clinically indicated” [9].
The clinical aim of defining the ideal volume status is more urgent in PD population, as some
trials imply that PD patients are much more volume-overloaded than HD patients [10]. This
finding depends on the methods used for assessing volume status; bioimpedance techniques
showed that PD patients presented with higher ECV compared with HD patients, even before
the hemodialysis session [10, 11], while serum biomarker levels had no differences between
them.
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Gold standard methods of assessing volume status are mainly isotope dilution analysis
techniques. Deuterium and tritium dilution are preferred means to measure total body water
(TBW), while bromine chloride and sucrose dilution yield data on ECV [12]. DEXA dual-
energy X-ray absorptiometry can provide data about fat mass, lean soft tissue mass, and bone
tissue mass [13]. However, these methods are invasive, expensive, and unfeasible in clinical
routine.
A number of practical bedside methods have been developed focusing on objective fluid status
assessment, both in HD and PD patients. Bioimpedance techniques can estimate ECV,
intracellular volume (ICV), and TBW, whereas inferior vena cava diameter measurements,
biochemical markers (such as atrial natriuretic peptide, ANP and brain natriuretic peptide,
BNP), and lung ultrasound provide information about the intravascular filling state/blood
volume (Table 1).
2. How to assess fluid status
2.1. Inferior vena cava diameter
Measurement of the diameter of inferior vena cava (IVC) and its decrease on deep inspiration
(collapsibility index––CI) by echocardiography allows an accurate assessment of dry weight
in hemodialysis patients. The diameter of IVC is usually expressed as an index to the body
surface area in mm/m2 [14]. Similarly, in PD populations, the IVC diameter, especially maximal
diameter in quiet expiration (IVCe), significantly correlates with cardiothoracic ratio and
plasma ANP concentration [15]. Toprak et al. [16] proved that IVC index is a useful tool for
assessing the volume status in PD patients and an independent predictor of left ventricular
geometric stratification.
However, some caveats should be kept in mind: (i) there is a wide variation of IVC diameters
in healthy individuals, and single measurements are not helpful; (ii) there is a significant,
inverse correlation between IVC diameters and heart rate, and the precision of intravascular
volume assessment is improved by correcting for the heart rate; and (iii) the presence of
tricuspid insufficiency leads to unreliable results [17]. Based on these remarks, IVC diameters
should be performed by an experienced cardiologist. Finally, we should keep in mind that IVC
estimates only intravascular volume.
2.2. Biomarkers
BNP is a peptide hormone that is released primarily by the ventricular myocytes in response
to myocyte stretch such as increased cardiac filling pressure. It is synthesized as an inactive
prohormone (108 amino acid pro-BNP) and is cleaved into the biologically active fragment (32
amino acid c-BNP) and the N-terminal pro-B-type natriuretic peptide (76 amino acid NT-pro-
BNP), and both are measurable in plasma or serum. Both provide strong prognostic informa‐
tion in patients with heart failure, coronary artery disease, and acute coronary syndrome. In
chronic kidney disease, their concentrations are often increased due to extracellular volume
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expansion, concomitant heart disease, and reduced renal clearance [18]. These molecules have
been associated with left ventricular hypertrophy [19, 20] and increased cardiovascular and
overall mortality in HD and PD populations [21].
In ADEMEX study, only NT-proBNP levels, but not the other peptides, were alone predictive
of overall survival and cardiovascular mortality of PD patients, independent of volume
overload [22]. Plasma BNP levels are known to decrease significantly after a HD session,
implying that volume overload is an important stimulus for BNP secretion. In PD populations,
plasma BNP and NT pro-BNP levels are elevated and correlate with volume overload [23].
However, there is uncertainty if elevated levels represent more a cardiac dysfunction than
volume overload [24] and doubt its use in determining volume status.
Cardiac troponins T and I (cTnT and cTnI) are subunits of the cardiac actin–myosin complex,
which pass through the circulation during myocardial damage, and their detection has been
used as a sensitive and specific marker of myocardial cell necrosis. Elevated serum levels of
cTnT have been associated with mortality in hemodialysis [25] and CAPD patients [26].
However, as its levels are strongly associated with increased left ventricular mass [26, 27], its
prognostic value is controversial. Finally, a study with HD patients from Korea compared three
biomarkers (NT-proBNP, hsCRP, and cTnT) regarding the prognosis of mortality. The study
concluded that NT-proBNP is a more significant prognostic factor for cardiovascular mortality
than cTnT and hsCRP, whereas hsCRP is a more significant predictor than NT-proBNP and
cTnT for all-cause mortality [28] So far, the data suggest that the above peptides are elevated
in PD patients and correlate well with echocardiographic left ventricular parameters. Their
elevated levels independently identify a subset of patients at greater risk for death, but they
cannot assess volume status [29].
2.3. Bioelectrical impedance techniques
Bioimpedance techniques pass a low-strength alternating current into the body, and biological
tissues react to the flow according to the current frequency and the properties of the tissue (this
is called impedance). The two basic properties of impedance are resistance and capacitance;
the former measures the flow of the electrons through the tissue, and the latter refers to how
much energy is stored and released in each current alternating cycle. Resistance is proportional
to the amount of fluid, while capacitance is proportional to the cell mass. Low-frequency
currents (<5 kHz) pass through the ECV (they cannot pass the cell membrane), while high-
frequency currents pass through both ECV and ICV compartments. There are different
methods of capturing these information and illustrate them in a simple way: segmental or
whole body bioimpedance spectroscopy (BIS), single or multifrequency, absolute volumes or
vectors [30].
In hemodialysis populations, multifrequency bioimpedance spectroscopy (BIS) methods have
been used, either segmental (measures the change of the resistance in the arm, trunk, or calf)
or whole body. The segmental BIS cannot be used in PD populations, as the method presumes
rapid volume reduction (as in a HD session) in order to monitor the resistance. Whole body
BIS has been used widely in both populations for years in devices such as Body Composition
Monitor (BCM, Fresenius Medical), Hydra (Hitron), Cyprus version 1.0 (BIA-101; RJL/Akern
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Systems), and so on. The devices offer the ability to perform frequent, rapid, noninvasive
assessment of the volume status.
The BCM device measures not only 50 frequencies over a range from 3 to 1000 kHz to determine
the electrical resistances of TBW and the extracellular water (ECW) status, but it can also
evaluate lean body weight and fat mass. This is of great interest, as there is convincing evidence
for an association between volume status, inflammation, and nutritional status [31]. The ratio
ECW/TBW is most widely accepted to be an index of hydration. Using population data, it also
provides an estimate of the amount of overhydration (OH, measured in liters). The vector plot
enables visualization of the trend toward the body composition changes, but it is inconvenient
as most clinicians prefer the volume to be expressed in liters or kilos [32]. All of the bioimpe‐
dance techniques are highly reproducible and validated with dilution methods [33]. However,
differences in results may occur mainly due to different devices, mathematical models used
for the equations, and lack of standardization.
Numerous studies have proven the ability of BIS to estimate volume status in hemodialysis
patients. In a study in HD patients [34], four different techniques for assessment of volume
status were compared in order to detect the limits of each method: the measurement of vena
cava diameter, vena cava collapsibility index, the blood volume drop during an ultrafiltration
bolus, and the ECV determined with whole body BIS. BIS proved to have the best low-detection
limit of volume overload. In PD populations, the majority of BIS-associated studies are
observational ones. The largest observational longitudinal trial was performed in multiple
European centers and included almost 1100 patients (IPOD-PD study) [35]. The study revealed
that the majority (56.4%) of patients was overhydrated with a mean absolute value of OH 1.9
± 2.4 l even at the start of the therapy, despite the fact the clinicians had clinically judged that
40% were normohydrated. Overhydration was commoner in males, diabetics, and fast
transporters.
There is an issue if the full abdomen affects BIS measurements. Davenport et al. [36] showed
that multifrequency BIS provides different measurements when the abdomen is empty.
Electrical resistance increased with fluid instilled, and the BIS software algorithms overesti‐
mated muscle mass more than fat mass. This difference is greater in younger patients, in those
with a poorer nutrition status (lower body mass index) and in those with a smaller fluid
overload. These findings were confirmed by Arroyo et al. [37]. So, the ideal BIS measurements
should be performed with empty abdomen. However, as this is clinically impractical, most
authors agree that the differences in measurements are probably not clinically significant,
provided they are made in a standardized way and are performed serially to document
changes rather than absolute values.
In hemodialysis populations, BIS has been widely used as a tool for intervening in the
evaluation of ideal dry weight [38, 39]. Similar studies in PD populations have proved the
value of BCM measurements in aiding the physicians in clinical decisions [40, 41]. In a
randomized controlled study in 160 continuous ambulatory peritoneal patients, fluid status
was evaluated by means of repeated BIS analysis versus only clinical assessment, and the
intervention group proved to be better controlled [41]. Another large randomized blinded
study conducted in the United Kingdom and Shanghai [42] attempted to determine whether
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assessment of volume status supported by the longitudinal plot of the BI vector resulted in
more stable fluid status than control subjects (where routine clinical judgment was used).
Vector plot added little additional value to clinical fluid management.
There is one randomized controlled trial in HD patients, which aimed to prove that volume
control guided by objective assessment of fluid overload via BIS led to improved cardiovas‐
cular outcome, namely a significant decrease in left ventricular mass index and improved
blood pressure control [43]. Such a study has not yet been published in PD populations.
Several studies associated overhydration measured by BIS with mortality [44]. A retrospective
study correlated hydration parameters with mortality in a PD population of above 500 patients
from the United Kingdom [45]. The study used OH (l), OH/ECW ratio, and ECW/TBW ratio
as volume status measurements. The first two parameters were independent predictors of
mortality. In a trial from China [46], overhydration (expressed as the ratio of extracellular to
intracellular water) was a predictor of mortality. The same conclusion was proved in a Korean
population (overhydration was expressed as the ratio of extracellular fluid to total body fluid)
[5].
BIS methods have some limitations in PD populations [47]. First, the ratio ECW/TBW is
disproportionally increased due to absolute reduction in tissue mass, mainly muscle mass and
abnormal tissue hydration [48, 49]. Hypoalbuminemia is another feature of PD patients, more
intense than in hemodialysis patients and highly associated with comorbidity. PD patients
have large protein losses through the membrane, especially high transporters and inflamed
patients [49]. It is proved that in HD population without comorbidity, BIS can identify an
increase in TBW and lean body mass, whereas with increasing comorbidity burden, BIS fails
to demonstrate increases in tissue hydration identified only by gold standard deuterium
methods [50]. As a result, in all dialysis patients, deteriorating fluid status by BIS is strongly
correlated with hypoalbuminemia; this association is stronger in PD population. Secondly,
clinicians should keep in mind that those absolute values of BIS measurements are based on
equations derived from healthy populations (whose body composition and fluid distribution
are quite different from dialysis patients). Finally, BIS cannot discriminate intravascular versus
extravascular volume.
2.4. Lung ultrasound
It is a novel, reproducible validated technique that has been applied to estimate lung water in
ESRD patients. The technique is based on the fact that when lung congestion is present, the
ultrasound beam is reflected by thickened interlobular septa, generating hyperechoic artifacts
between edematous septa and the overlying pleura (the so-called lung comets, considered as
a ultrasound equivalent of B-lines detected in chest X-rays) (Figure 1). The number of these
lung comets is associated with left ventricular filling pressure. Extravascular lung water is
related to the ventricular filling pressure of the left ventricle [51, 52]. The technique can be
easily learnt by a noncardiologist and can be performed by the bed.
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Figure 1. Lung ultrasound. The arrow shows a B-line (lung comet).
The power of the method lies in its capacity in detecting clinically asymptomatic pulmonary
congestion, which is the most early and important determinator of volume overload [53].
Indeed, in a study which included HD patients [54], lung ultrasound revealed moderate-to-
severe lung congestion in 63% of patients before the dialysis, even in asymptomatic ones. The
number of the lung comets decreased at the end of HD session. Lung water excess was mainly
associated with New York Heart Association (NYHA) functional class, left ventricular ejection
fraction, left atrial volume, and pulmonary pressure. Zoccali et al. [55] proved in a multicenter
study including hemodialysis patients that lung ultrasound can detect asymptomatic pulmo‐
nary congestion, and that the number of lung comets can be a strong, independent predictor
of mortality and cardiac events in this population.
Another study from Romania [56] evaluated three different methods––lung ultrasonography
(predialysis and postdialysis), bioimpedance spectroscopy (predialysis and postdialysis), and
echocardiography (predialysis)––in order to test their prognostic value in mortality. Only
predialysis lung comets score and left ventricular mass index were significant factors for
survival.
However, similar studies in PD populations are sparse. Only two observational trials have
been published. A multicenter study from Italy included 88 PD patients [57] and compared
lung echo score, echocardiographic parameters, BIS parameters, and clinical estimation such
as edema and NYHA class. Moderate-to-severe lung congestion was evident in 46% of patients,
and it was mainly associated with ejection fraction and NYHA class. Edema or BIS measure‐
ments did not correlate with the number of lung score. Another study from the United
Kingdom [58] assessed fluid status in 27 peritoneal dialysis patients using BIS, lung ultrasound,
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and N-terminal pro-brain natriuretic peptide (NT-proBNP). Contrary to the Italian study
discussed above [57], the number of patients with lung congestion was lesser (7%). There was
a statistically significant correlation between the lung score and NT-proBNP values, but such
a correlation was not evident between lung comets and BIS. The authors conclude that as lung
echocardiography and biomarkers detect intravascular and pulmonary volume excess while
BIS methods estimate overall hydration status, the methods can be complementary.
3. Conclusions
Estimation of ideal volume status of dialysis patients is a critical purpose of everyday clinical
practice, since volume overload is highly associated with mortality. The estimation of volume
status should be based on objective, practical, reproducible, and by the bed methods such as
bioimpedance, inferior vena cava diameter measurements, biochemical markers, and lung
ultrasound. Although all these methods can estimate overhydration and do predict mortality,
none so far has proved its value as an intervening tool for modifying cardiac parameters,
cardiovascular events, and survival in PD patients. As these techniques estimate different fluid
compartments of the body, the information provided by the combination of them could be compli‐
mentary and more effective in the assessment of volume status.
Author details
Olga Balafa
Address all correspondence to: olgabalafa@gmail.com
Department of Nephrology, University Hospital of Ioannina, Ioannina, Greece
References
[1] Agarwal R, Bouldin JM, Light RP, Garg A. Probing dry-weight improves left ventricular
mass index. Am J Nephrol. 2011;33(4):373–80. Epub 2011/03/31.
[2] Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich
TB, et al. Fluid retention is associated with cardiovascular mortality in patients
undergoing long-term hemodialysis. Circulation. 2009;119(5):671–9. Epub 2009/01/28.
[3] Parker TF, 3rd, Hakim R, Nissenson AR, Krishnan M, Bond TC, Chan K, et al. A quality
initiative. Reducing rates of hospitalizations by objectively monitoring volume
removal. Nephrol News Issues. 2013;27(3):30–2, 4–6. Epub 2013/04/16.
Some Special Problems in Peritoneal Dialysis76
[4] Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP,
et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on
peritoneal dialysis. Perit Dial Int. 2002;22(4):477–87. Epub 2002/09/27.
[5] Kang SH, Choi EW, Park JW, Cho KH, Do JY. Clinical significance of the edema index
in incident peritoneal dialysis patients. PLoS One. 2016;11(1):e0147070. Epub
2016/01/20.
[6] Agarwal R, Weir MR. Dry-weight: a concept revisited in an effort to avoid medication-
directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc
Nephrol. 2010;5(7):1255–60. Epub 2010/05/29.
[7] Krediet RT, Smit W, Coester AM, Struijk DG. Dry body weight and ultrafiltration
targets in peritoneal dialysis. Contrib Nephrol. 2009;163:90–5. Epub 2009/06/06.
[8] Agarwal R, Andersen MJ, Pratt JH. On the importance of pedal edema in hemodialysis
patients. Clin J Am Soc Nephrol. 2008;3(1):153–8. Epub 2007/12/07.
[9] Wang AY, Brimble KS, Brunier G, Holt SG, Jha V, Johnson DW, et al. ISPD cardiovas‐
cular and metabolic guidelines in adult peritoneal dialysis patients part i - assessment
and management of various cardiovascular risk factors. Perit Dial Int. 2015;35(4):379–
87. Epub 2015/08/01.
[10] Plum J, Schoenicke G, Kleophas W, Kulas W, Steffens F, Azem A, et al. Comparison of
body fluid distribution between chronic haemodialysis and peritoneal dialysis patients
as assessed by biophysical and biochemical methods. Nephrol Dial Transplant.
2001;16(12):2378–85. Epub 2001/12/06.
[11] Devolder I, Verleysen A, Vijt D, Vanholder R, Van Biesen W. Body composition,
hydration, and related parameters in hemodialysis versus peritoneal dialysis patients.
Perit Dial Int. 2010;30(2):208–14. Epub 2010/01/19.
[12] Woodrow G, Oldroyd B, Turney JH, Davies PS, Day JM, Smith MA. Four-component
model of body composition in chronic renal failure comprising dual-energy X-ray
absorptiometry and measurement of total body water by deuterium oxide dilution.
Clin Sci (Lond). 1996;91(6):763–9. Epub 1996/12/01.
[13] Woodrow G, Oldroyd B, Turney JH, Tompkins L, Brownjohn AM, Smith MA. Whole
body and regional body composition in patients with chronic renal failure. Nephrol
Dial Transplant. 1996;11(8):1613–8. Epub 1996/08/01.
[14] Cheriex EC, Leunissen KM, Janssen JH, Mooy JM, van Hooff JP. Echography of the
inferior vena cava is a simple and reliable tool for estimation of 'dry weight' in haemo‐
dialysis patients. Nephrol Dial Transplant. 1989;4(6):563–8. Epub 1989/01/01.
[15] Sakurai T, Ando Y, Masunaga Y, Kusano E, Asano Y. Diameter of the inferior vena cava
as an index of dry weight in patients undergoing CAPD. Perit Dial Int. 1996;16(2):183–
5. Epub 1996/03/01.
Assessment of Volume Status in Peritoneal Dialysis Patients
http://dx.doi.org/10.5772/64023
77
[16] Toprak A, Koc M, Tezcan H, Ozener IC, Akoglu E, Oktay A. Inferior vena cava diameter
determines left ventricular geometry in continuous ambulatory peritoneal dialysis
patients: an echocardiographic study. Nephrol Dial Transplant. 2003;18(10):2128–33.
Epub 2003/09/19.
[17] Mandelbaum A, Ritz E. Vena cava diameter measurement for estimation of dry weight
in haemodialysis patients. Nephrol Dial Transplant. 1996;11 Suppl 2:24–7. Epub
1996/01/01.
[18] Crepaldi C, Lamas EI, Martino FK, Rodighiero MP, Scalzotto E, Wojewodzka-Zelez‐
niakowicz M, et al. Bioimpedance and brain natriuretic peptide in peritoneal dialysis
patients. Contrib Nephrol. 2012;178:174–81. Epub 2012/06/02.
[19] Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac
natriuretic peptides are related to left ventricular mass and function and predict
mortality in dialysis patients. J Am Soc Nephrol. 2001;12(7):1508–15. Epub 2001/06/26.
[20] Lee JA, Kim DH, Yoo SJ, Oh DJ, Yu SH, Kang ET. Association between serum n-terminal
pro-brain natriuretic peptide concentration and left ventricular dysfunction and
extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial
Int. 2006;26(3):360–5. Epub 2006/05/26.
[21] Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, et al. N-terminal pro-brain
natriuretic peptide: an independent risk predictor of cardiovascular congestion,
mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
J Am Soc Nephrol. 2007;18(1):321–30. Epub 2006/12/15.
[22] Paniagua R, Ventura MD, Avila-Diaz M, Hinojosa-Heredia H, Mendez-Duran A,
Cueto-Manzano A, et al. NT-proBNP, fluid volume overload and dialysis modality are
independent predictors of mortality in ESRD patients. Nephrol Dial Transplant.
2010;25(2):551–7. Epub 2009/08/15.
[23] Davenport A. Changes in N-terminal pro-brain natriuretic peptide correlate with fluid
volume changes assessed by bioimpedance in peritoneal dialysis patients. Am J
Nephrol. 2012;36(4):371–6. Epub 2012/10/12.
[24] Papakrivopoulou E, Booth J, Pinney J, Davenport A. Comparison of volume status in
asymptomatic haemodialysis and peritoneal dialysis outpatients. Nephron Extra.
2012;2(1):48–54. Epub 2012/05/24.
[25] deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, et al. Cardiac
troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis,
and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA.
2003;290(3):353–9. Epub 2003/07/17.
[26] Duman D, Tokay S, Toprak A, Duman D, Oktay A, Ozener IC, et al. Elevated cardiac
troponin T is associated with increased left ventricular mass index and predicts
Some Special Problems in Peritoneal Dialysis78
mortality in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Trans‐
plant. 2005;20(5):962–7. Epub 2005/03/03.
[27] Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, et al. Diagnostic
value of troponin T for alterations in left ventricular mass and function in dialysis
patients. Kidney Int. 2002;62(5):1884–90. Epub 2002/10/10.
[28] Oh HJ, Lee MJ, Lee HS, Park JT, Han SH, Yoo TH, et al. NT-proBNP: is it a more
significant risk factor for mortality than troponin T in incident hemodialysis patients?
Medicine (Baltimore). 2014;93(27):e241. Epub 2014/12/17.
[29] Garg R, Singh A, Khaja A, Martin A, Aggarwal K. How does volume status affect BNP
and troponin levels as markers of cardiovascular status in peritoneal dialysis? Congest
Heart Fail. 2009;15(5):240–4. Epub 2009/09/16.
[30] Davies SJ, Davenport A. The role of bioimpedance and biomarkers in helping to aid
clinical decision-making of volume assessments in dialysis patients. Kidney Int.
2014;86(3):489–96. Epub 2014/06/12.
[31] Cheng LT, Tang W, Wang T. Strong association between volume status and nutritional
status in peritoneal dialysis patients. Am J Kidney Dis. 2005;45(5):891–902. Epub
2005/04/30.
[32] Piccoli A. Whole body--single frequency bioimpedance. Contrib Nephrol.
2005;149:150–61. Epub 2005/05/07.
[33] Konings CJ, Kooman JP, Schonck M, Cox-Reijven PL, van Kreel B, Gladziwa U, et al.
Assessment of fluid status in peritoneal dialysis patients. Perit Dial Int. 2002;22(6):683–
92. Epub 2003/01/31.
[34] Kraemer M, Rode C, Wizemann V. Detection limit of methods to assess fluid status
changes in dialysis patients. Kidney Int. 2006;69(9):1609–20. Epub 2006/02/28.
[35] Ronco C, Verger C, Crepaldi C, Pham J, De Los Rios T, Gauly A, et al. Baseline hydration
status in incident peritoneal dialysis patients: the initiative of patient outcomes in
dialysis (IPOD-PD study)dagger. Nephrol Dial Transplant. 2015;30(5):849–58. Epub
2015/03/13.
[36] Davenport A. Effect of intra-abdominal dialysate on bioimpedance-derived fluid
volume status and body composition measurements in peritoneal dialysis patients.
Perit Dial Int. 2013;33(5):578–9. Epub 2013/10/18.
[37] Arroyo D, Panizo N, Abad S, Vega A, Rincon A, de Jose AP, et al. Intraperitoneal fluid
overestimates hydration status assessment by bioimpedance spectroscopy. Perit Dial
Int. 2015;35(1):85–9. Epub 2014/03/04.
[38] Liu L, Zhu F, J GR, Thijssen S, Sipahioglu MH, Wystrychowski G, et al. Determination
of fluid status in haemodialysis patients with whole body and calf bioimpedance
techniques. Nephrology (Carlton). 2012;17(2):131–40. Epub 2011/09/29.
Assessment of Volume Status in Peritoneal Dialysis Patients
http://dx.doi.org/10.5772/64023
79
[39] Passauer J, Petrov H, Schleser A, Leicht J, Pucalka K. Evaluation of clinical dry weight
assessment in haemodialysis patients using bioimpedance spectroscopy: a cross-
sectional study. Nephrol Dial Transplant. 2010;25(2):545–51. Epub 2009/10/08.
[40] van Biesen W, Claes K, Covic A, Fan S, Lichodziejewska-Niemierko M, Schoder V, et
al. A multicentric, international matched pair analysis of body composition in perito‐
neal dialysis versus haemodialysis patients. Nephrol Dial Transplant. 2013;28(10):
2620–8. Epub 2013/10/01.
[41] Luo YJ, Lu XH, Woods F, Wang T. Volume control in peritoneal dialysis patients guided
by bioimpedance spectroscopy assessment. Blood Purif. 2011;31(4):296–302. Epub
2011/01/19.
[42] T an BK, Yu Z, Fang W, Lin A, Ni Z, Qian J, et al. Longitudinal bioimpedance vector
plots add little value to fluid management of peritoneal dialysis patients. Kidney Int.
2016;89(2):487-497. Epub 2016/01/22
[43] Hur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S, et al. Effect of fluid management
guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis
patients: a randomized controlled trial. Am J Kidney Dis. 2013;61(6):957–65. Epub
2013/02/19.
[44] Koh KH, Wong HS, Go KW, Morad Z. Normalized bioimpedance indices are better
predictors of outcome in peritoneal dialysis patients. Perit Dial Int. 2011;31(5):574–82.
Epub 2010/07/02.
[45] O'Lone EL, Visser A, Finney H, Fan SL. Clinical significance of multi-frequency
bioimpedance spectroscopy in peritoneal dialysis patients: independent predictor of
patient survival. Nephrol Dial Transplant. 2014;29(7):1430–7. Epub 2014/03/07.
[46] Chen W, Guo LJ, Wang T. Extracellular water/intracellular water is a strong predictor
of patient survival in incident peritoneal dialysis patients. Blood Purif. 2007;25(3):260–
6. Epub 2007/04/13.
[47] Tan BK, Chan C, Davies SJ. Achieving euvolemia in peritoneal dialysis patients: a
surprisingly difficult proposition. Semin Dial. 2010;23(5):456–61. Epub 2010/11/03.
[48] Woodrow G, Devine Y, Cullen M, Lindley E. Application of bioelectrical impedance to
clinical assessment of body composition in peritoneal dialysis. Perit Dial Int. 2007;27(5):
496–502. Epub 2007/08/21.
[49] John B, Tan BK, Dainty S, Spanel P, Smith D, Davies SJ. Plasma volume, albumin, and
fluid status in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2010;5(8):1463–70.
Epub 2010/06/12.
[50] Chan C, McIntyre C, Smith D, Spanel P, Davies SJ. Combining near-subject absolute
and relative measures of longitudinal hydration in hemodialysis. Clin J Am Soc
Nephrol. 2009;4(11):1791–8. Epub 2009/10/08.
Some Special Problems in Peritoneal Dialysis80
[51] Picano E, Frassi F, Agricola E, Gligorova S, Gargani L, Mottola G. Ultrasound lung
comets: a clinically useful sign of extravascular lung water. J Am Soc Echocardiogr.
2006;19(3):356–63. Epub 2006/02/28.
[52] Gargani L, Frassi F, Soldati G, Tesorio P, Gheorghiade M, Picano E. Ultrasound lung
comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with
natriuretic peptides. Eur J Heart Fail. 2008;10(1):70–7. Epub 2007/12/14.
[53] Zoccali C, Puntorieri E, Mallamaci F. Lung congestion as a hidden threat in end-stage
kidney disease: a call to action. Nephrol Dial Transplant. 2013;28(11):2657–60. Epub
2013/10/31.
[54] Mallamaci F, Benedetto FA, Tripepi R, Rastelli S, Castellino P, Tripepi G, et al. Detection
of pulmonary congestion by chest ultrasound in dialysis patients. JACC Cardiovasc
Imaging. 2010;3(6):586–94. Epub 2010/06/15.
[55] Zoccali C, Torino C, Tripepi R, Tripepi G, D'Arrigo G, Postorino M, et al. Pulmonary
congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol.
2013;24(4):639–46. Epub 2013/03/02.
[56] Siriopol D, Voroneanu L, Hogas S, Apetrii M, Gramaticu A, Dumea R, et al. Bioimpe‐
dance analysis versus lung ultrasonography for optimal risk prediction in hemodialysis
patients. Int J Cardiovasc Imaging. 2016;32(2):263–70. Epub 2015/10/03.
[57] Panuccio V, Enia G, Tripepi R, Torino C, Garozzo M, Battaglia GG, et al. Chest ultra‐
sound and hidden lung congestion in peritoneal dialysis patients. Nephrol Dial
Transplant. 2012;27(9):3601–5. Epub 2012/05/11.
[58] Paudel K, Kausik T, Visser A, Ramballi C, Fan SL. Comparing lung ultrasound with
bioimpedance spectroscopy for evaluating hydration in peritoneal dialysis patients.
Nephrology (Carlton). 2015;20(1):1–5. Epub 2014/09/19.
Assessment of Volume Status in Peritoneal Dialysis Patients
http://dx.doi.org/10.5772/64023
81

